|
Alydar Pharmaceuticals received seed funding from Medison Biotech to develop its library of infochemicals, demonstrate proof of concept of the Pheromics™ drug-product platform, and to pursue early-stage drug development. Alydar seeks Series A investment funding to expand its operations aimed at commercializing its Pheromics™ drug-product platform and to develop new therapeutic products.
|
 |
